title: CD8 T cell response to Nef peptides and HIV type 1 control in early-treated patients after antiretroviral treatment interruption.
authors.forename: Fabrizio
authors.initials: F
authors.lastname: Poccia
authors.forename: Cristiana
authors.initials: C
authors.lastname: Gioia
authors.forename: Angela
authors.initials: A
authors.lastname: Corpolongo
authors.forename: Gianpiero
authors.initials: G
authors.lastname: D'Offizi
authors.forename: Pasquale
authors.initials: P
authors.lastname: Narcisco
authors.forename: Federico
authors.initials: F
authors.lastname: Martini
mesh_terms: D000595:Amino Acid Sequence; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D018414:CD8-Positive T-Lymphocytes / Q000166:cytology; D002908:Chronic Disease; D016384:Consensus Sequence; D004334:Drug Administration Schedule; D004797:Enzyme-Linked Immunosorbent Assay; D000939:Epitopes; D015693:Gene Products, nef; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D015497:HIV-1 / Q000235:genetics* / Q000302:isolation & purification; D006801:Humans; D007370:Interferon Type I / Q000096:biosynthesis; D008969:Molecular Sequence Data; D010455:Peptides / Q000627:therapeutic use*; D012367:RNA, Viral / Q000097:blood; D013997:Time Factors; D019562:Viral Load; D014779:Virus Replication; D054311:nef Gene Products, Human Immunodeficiency Virus
chemical_list: D019380:Anti-HIV Agents; D000939:Epitopes; D015693:Gene Products, nef; D007370:Interferon Type I; D010455:Peptides; D012367:RNA, Viral; D054311:nef Gene Products, Human Immunodeficiency Virus